How Long Does a Psilocybin Microdose Last? Onset, Duration, and What Research Shows

How long does a psilocybin microdose last? See what research says about onset, peak effects, psilocin half-life, aftereffects, and why timing varies. Research gives us useful information about psilocin absorption and full-dose psilocybin, but the duration of a true microdose is less established than many online guides suggest.

How Long Does a Psilocybin Microdose Last? Onset, Duration, and What Research Shows

How long does a psilocybin microdose last? The most scientifically defensible answer is that researchers do not yet know the precise duration of a true psilocybin microdose. We know much more about how oral psilocybin is absorbed and metabolized than we do about the minute-by-minute experience of microdosing. Psilocybin is rapidly converted into psilocin, its primary psychoactive metabolite. Human pharmacokinetic studies generally find that psilocin concentrations rise during the first few hours after oral psilocybin, while studies using larger doses commonly report an acute subjective effect window of roughly five to six hours.

Microdosing research is different. Several controlled studies have measured people around the expected peak period after a low dose, but surprisingly few were designed to answer the simple question people actually type into Google: when does a psilocybin microdose start, peak, and completely wear off? That distinction matters. Saying that every mushroom microdose lasts exactly four, five, or six hours makes the evidence sound more precise than it currently is.

The Quick Answer

Here is what current research can reasonably tell us:

• Oral psilocybin is converted into psilocin relatively quickly.
• Psilocin concentrations in controlled human studies commonly reach their maximum roughly one to three hours after ingestion.
• A 2025 systematic review found reported psilocin peak times ranging from about 1.05 to 3.71 hours after oral psilocybin.
• Controlled studies using conventional psilocybin doses have reported subjective effects lasting around five to six hours on average.
• Microdosing studies often conduct acute testing approximately 1.5 hours after ingestion because researchers expect psilocin exposure to be near its peak around that period.
• There is not yet a strong body of research establishing an exact start-to-finish duration specifically for psilocybin microdoses.
• Feeling different the following day does not necessarily mean psilocin is still producing an acute drug effect.

So when someone asks how long a psilocybin microdose lasts, a four-to-six-hour window may be a useful reference point for oral psilocybin pharmacology, but it should not be presented as a scientifically established microdose duration.

What Happens After Psilocybin Is Ingested?

Psilocybin itself is often described as a prodrug. After oral ingestion, the body rapidly converts much of the psilocybin into psilocin. Psilocin is the compound primarily responsible for psilocybin's psychoactive activity, including its interaction with serotonin receptors such as the 5-HT2A receptor. A major systematic review published in Clinical Pharmacokinetics in 2025 examined human pharmacokinetic data across 19 publications representing 12 unique clinical datasets. Across those studies, psilocin generally reached maximum concentrations between approximately 1.05 and 3.71 hours following oral psilocybin administration, with many results clustering around two hours.

The researchers reported terminal psilocin half-lives ranging from approximately 1.23 to 4.72 hours. Those numbers provide an important biological framework for understanding psilocybin duration. They do not, however, tell us exactly how long someone will feel a microdose.

When Does a Psilocybin Microdose Kick In?

This is another search question with a deceptively complicated answer. Microdose-specific studies have not established a universal onset time. Researchers have often scheduled measurements around 90 minutes after ingestion because previous psilocybin research suggested that plasma psilocin levels and subjective effects would be approaching their strongest point around that period. For example, researchers studying psilocybin microdosing at the University of Amsterdam scheduled laboratory sessions approximately 1.5 hours after participants consumed their capsules.

That tells us something important about when researchers expect acute pharmacological activity to be present. It does not prove that everyone taking a mushroom microdose should notice something at exactly 90 minutes. In fact, whether a true microdose should be consciously noticeable at all remains part of the definitional problem surrounding microdosing.

A Microdose Is Not Just a Smaller Full Dose

It is tempting to take what researchers know about a larger psilocybin dose and simply scale the timeline downward. Biology is rarely that simple. In one controlled pharmacokinetic study, researchers examined oral doses of 15, 25, and 30 milligrams of psilocybin in healthy participants. Maximum psilocin concentrations were reached after approximately two hours. Average durations of subjective effects were:

• About 5.6 hours in the 15 milligram condition
• About 5.5 hours in the 25 milligram condition
• About 6.4 hours in the 30 milligram condition

Those are valuable data. They are not microdosing data. The doses were considerably larger than amounts normally discussed in the context of microdosing and produced substantial subjective effects. The study therefore helps establish the general pharmacological timeline of oral psilocybin but cannot establish that a microdose lasts the same length of time.

This is one of the most important distinctions to understand when reading claims about microdose duration online.

What Microdosing Studies Actually Found

The controlled psilocybin microdosing literature is still relatively small, but it is growing. A 2022 double-blind, placebo-controlled study examined 34 people who were beginning to microdose with Psilocybe cubensis mushrooms. Participants received 0.5 grams of dried mushroom material during active conditions. Researchers found stronger acute subjective effects in the active condition, although the difference was associated with participants correctly identifying whether they had received psilocybin or placebo. The researchers did not find convincing evidence for the commonly claimed improvements in well-being, creativity, or cognitive performance.

The study is useful because it demonstrates something often lost in popular descriptions of microdosing: low doses can sometimes produce noticeable acute effects. Another series of studies used psilocybin-containing truffles and conducted laboratory testing approximately 1.5 hours after participants took their dose. Researchers selected that timing because earlier psilocybin research suggested plasma psilocin concentrations would be near their peak. Again, these studies were primarily designed to measure psychological, emotional, or cognitive outcomes rather than determine exactly how many hours a microdose remains subjectively active.

That leaves a surprisingly basic question incompletely answered.

Newer Research Has Not Solved the Duration Question

Microdosing research continued to develop after many of the studies commonly cited online. A study published in Neuropharmacology in 2026 reported results from two randomized, double-blind, placebo-controlled longitudinal trials of psilocybin truffle microdosing. Researchers examined cognitive control, memory, social cognition, mood, well-being, and subjective experiences. They found no reliable improvement in cognitive or emotional functioning compared with placebo after appropriate statistical corrections. Participants remained effectively blinded, which is particularly important in psychedelic research because noticeable effects can reveal who received the active substance.

Interestingly, negative bodily sensations were increased in the active microdosing condition. The study strengthens the controlled evidence surrounding what microdosing may or may not do. It still does not establish a universal microdose duration. That is a recurring theme in this field: researchers are beginning to answer increasingly sophisticated questions about microdosing while some basic questions about the acute experience remain surprisingly difficult to answer precisely.

Psilocin Half-Life Is Not the Same as How Long a Microdose Lasts

Half-life is one of the most frequently misunderstood terms in discussions about psychoactive substances. The half-life of a compound describes how long it takes for its concentration in the body to decrease by approximately half under the conditions being measured. It does not mean that the effects suddenly stop when one half-life has passed. It also does not mean the substance is completely gone.

The 2025 pharmacokinetic review found psilocin terminal half-life estimates ranging approximately from 1.23 to 4.72 hours across available studies. Another controlled human study reported elimination half-lives around 1.4 to 1.8 hours for the psilocybin doses it examined. Meanwhile, subjective effects lasted considerably longer than a single half-life. Drug concentration, receptor activity, brain response, psychological experience, and measurable impairment are related concepts, but they are not interchangeable.

This is why answering “how long does psilocin stay in your body?” is not the same as answering “how long does a mushroom microdose last?”

Does a Microdose Have an Afterglow?

The word afterglow appears frequently in psychedelic discussions. It usually refers to changes in mood, outlook, emotional state, or cognition reported after the obvious acute effects of a psychedelic have ended. There is scientific evidence that larger psychedelic doses can sometimes be followed by changes lasting well beyond the period when the drug is acutely active. Researchers have studied persistent psychological and neurological changes after full psychedelic experiences.

But that evidence should not automatically be transferred to microdosing. A person reporting improved mood the day after a microdose is not evidence that psilocin remained pharmacologically active for 24 or 48 hours. It is also not enough to prove that the microdose caused the change. Expectation, sleep, stress, normal mood variation, behavior changes, and placebo effects can all complicate self-reported microdosing experiences.

Controlled research has repeatedly shown why those factors matter. An aftereffect and an acute drug effect are not the same thing.

Why Mushroom Microdose Duration Can Be Difficult to Predict

Research with standardized psilocybin is already complicated. Whole mushrooms add another variable. A gram of dried mushroom material is a measurement of mushroom weight, not a direct measurement of psilocybin. Alkaloid concentrations can vary between mushroom species, strains or genetic lines, individual fruiting bodies, different portions of the same mushroom, growing conditions, harvests, storage conditions, and prepared materials.

That means two portions with the same scale weight are not necessarily pharmacologically identical. We covered this issue more deeply in our article on psilocybin microdosing dosage and schedules: https://www.mycohub.app/myconews/psilocybin-microdosing-dosage-and-schedules-what-research-and-real-world-use-show Individual biology adds another layer.

Absorption, metabolism, medications, health conditions, tolerance, expectations, and other variables may influence what someone experiences. The 2025 pharmacokinetic review found relatively consistent psilocin pharmacokinetics across the available clinical studies, but there are still substantial gaps, particularly when trying to translate standardized clinical psilocybin data into real-world mushroom microdosing.

Does Food Change How Long a Psilocybin Microdose Lasts?

There is not enough evidence to give a confident microdosing-specific answer. The 2025 pharmacokinetic review examined the limited available information about food and found no clear effect on psilocin exposure across the small number of studies where fasting status was known. That does not establish that food never matters. It means the existing research is not strong enough to support the detailed claims frequently made online about precisely how eating, fasting, or meal timing changes psilocybin onset and duration.

This is another area where practical anecdotes have moved much faster than controlled evidence.

Does Tolerance Change the Duration?

Repeated exposure to classic psychedelics can produce tolerance, particularly through changes involving serotonin receptors. What that means specifically for repeated microdosing is less certain. A diminished subjective response does not necessarily mean the body is metabolizing psilocybin dramatically faster. Pharmacodynamic tolerance, meaning changes in how the body and brain respond to a substance, is different from pharmacokinetics, which describes absorption, distribution, metabolism, and elimination.

We examined that question separately in the previous article in this series: https://www.mycohub.app/myconews/does-psilocybin-microdosing-build-tolerance Understanding that distinction helps prevent another common misconception: weaker effects do not automatically mean the substance disappeared more quickly.

If a Microdose Produces Noticeable Effects, Is It Still a Microdose?

There is no universally accepted scientific definition. Microdoses are frequently described as sub-perceptual or sub-hallucinogenic doses, but controlled research complicates the idea that a microdose must produce absolutely no noticeable sensations. Some studies have found detectable subjective or bodily effects from quantities described as microdoses. That creates a terminology problem.

A dose can be far below a conventional psychedelic dose while still being noticeable. Researchers therefore increasingly need to specify the actual substance, measured amount when available, preparation, and observed effects rather than assuming the word microdose tells us everything. For readers, that means statements such as “you should never feel a microdose” or “you should definitely feel a slight effect” are both more confident than the scientific definition currently allows.

How Long Does a Mushroom Microdose Last Compared With LSD?

Psilocybin and LSD are both classic serotonergic psychedelics, but they have different pharmacokinetic profiles. They should not be treated as interchangeable when discussing duration. Oral psilocybin is generally shorter acting than LSD at conventional doses. Research terminology published in 2025 describes oral psilocybin as reaching maximum effects around an hour and producing subjective effects for approximately four to six hours under studied conditions, while LSD generally lasts substantially longer.

That difference is one reason search results about generic “microdosing” can be misleading. An article discussing LSD microdosing may not provide an appropriate timeline for psilocybin mushrooms. When searching for information, the substance matters.

Can You Drive or Work During a Psilocybin Microdose?

The popular description of microdosing as something that can simply be added to an ordinary workday should not be mistaken for an established safety finding. Controlled research shows that low doses of psilocybin can produce subjective effects, bodily sensations, and measurable changes even when dramatic psychedelic effects are absent. The scientific evidence does not establish a universal dose at which driving, operating machinery, working at heights, or performing other safety-sensitive activities becomes harmless.

If someone is experiencing altered perception, dizziness, anxiety, unusual stimulation, impaired concentration, or any other psychoactive effect, activities requiring unimpaired judgment carry obvious risk. Microdosing has also not been established by the FDA as an approved treatment, and the National Center for Complementary and Integrative Health notes that it remains unclear whether psilocybin microdosing is safe or effective. In the United States, psilocybin also remains federally controlled as a Schedule I substance, although state and local laws and enforcement policies vary.

How Long Does a Psilocybin Microdose Last? What We Can Actually Say

The research gives us a much better answer than it did a decade ago, but not the perfectly precise one that many search results promise. Oral psilocybin is converted rapidly into psilocin. Psilocin concentrations commonly reach their maximum during the first few hours following ingestion. Controlled studies with conventional psilocybin doses generally find acute subjective effects lasting several hours, often around five to six hours.

Microdose studies confirm that low doses can produce detectable acute effects and often schedule testing around 1.5 hours after ingestion. What they have not yet established is a universal timeline showing exactly when a true mushroom microdose begins, peaks, and ends. That is the key distinction. The pharmacology of psilocybin gives us a useful framework. It does not justify turning that framework into an exact promise about every microdose.

Frequently Asked Questions

How long does a psilocybin microdose last?

There is no scientifically established duration that applies to every psilocybin microdose. Oral psilocybin pharmacology occurs over several hours, and larger-dose studies commonly report acute subjective effects lasting roughly five to six hours. Microdose-specific studies have not established an equally precise start-to-finish duration.

When does a psilocybin microdose kick in?

Research does not establish one universal onset time for microdoses. Several microdosing studies performed testing around 1.5 hours after ingestion because previous psilocybin research suggested psilocin concentrations would be approaching their peak around that period.

When does psilocybin peak?

A 2025 systematic review of human pharmacokinetic studies found psilocin peak concentrations approximately 1.05 to 3.71 hours after oral psilocybin, with many studies clustering around roughly two hours.

What is the half-life of psilocin?

Published human studies have produced different estimates. A 2025 systematic review reported terminal half-lives ranging from approximately 1.23 to 4.72 hours. Half-life should not be confused with the exact duration of subjective effects.

Can a microdose affect you the next day?

People sometimes report next-day changes, but those reports do not prove psilocin remains acutely active. Persistent psychological effects, expectancy, sleep, behavior, mood variation, and other variables may all contribute. Evidence for a reliable next-day microdosing effect remains limited.

Why can the same mushroom weight feel different?

Mushroom weight does not directly equal psilocybin content. Alkaloid concentrations can vary between biological materials, so equal weights of dried mushrooms are not necessarily chemically equivalent.

Is four to six hours the correct microdose duration?

It is better understood as a general reference derived largely from oral psilocybin pharmacology and conventional-dose research. It has not been established as a universal duration for psilocybin microdoses.

The Bottom Line

If you search “how long does a psilocybin microdose last,” you will find plenty of precise answers. The research is less precise. We have increasingly good data on how psilocybin becomes psilocin, when psilocin concentrations peak, how it is eliminated, and how long conventional psilocybin doses produce acute effects. What researchers have not yet mapped nearly as well is the complete subjective timeline of a true microdose.

For now, the strongest conclusion is that psilocybin and psilocin act over a period of hours, not days, while any reported later changes should be separated from the acute pharmacological effect itself. That distinction may sound small, but it is exactly the kind of distinction that matters as microdosing moves from anecdotes and online protocols toward controlled scientific study. MycoNews will continue following the evidence as that research develops.

Continue the MycoNews Microdosing Series

Psilocybin Microdosing Dosage and Schedules: What Research and Real-World Use Show https://www.mycohub.app/myconews/psilocybin-microdosing-dosage-and-schedules-what-research-and-real-world-use-show What Is the Stamets Stack? Psilocybin, Lion’s Mane, Niacin, and What the Science Says https://www.mycohub.app/myconews/what-is-the-stamets-stack-psilocybin-lions-mane-niacin-and-what-the-science-says-2

Does Psilocybin Microdosing Build Tolerance? https://www.mycohub.app/myconews/does-psilocybin-microdosing-build-tolerance

Sources and Further Reading

Otto ME, van der Heijden KV, Schoones JW, et al. Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis. Clinical Pharmacokinetics. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC11762572/ Holze F, Becker AM, Kolaczynska KE, et al. Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants. Clinical Pharmacology & Therapeutics. 2023. https://pubmed.ncbi.nlm.nih.gov/36507738/

Cavanna F, Muller S, de la Fuente LA, et al. Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study. Translational Psychiatry. 2022. https://pubmed.ncbi.nlm.nih.gov/35918311/ van Elk M, Fejer G, Lempe P, et al. Effects of psilocybin microdosing on awe and aesthetic experiences: a preregistered field and lab-based study. Psychopharmacology. 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC9166866/

Marschall J, Fejer G, Lempe P, et al. Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study. Journal of Psychopharmacology. 2022. https://pubmed.ncbi.nlm.nih.gov/34915762/ Prochazkova L, Marschall J, Lippelt DP, et al. Cognitive and subjective effects of psilocybin microdosing: Results from two double-blind placebo-controlled longitudinal trials. Neuropharmacology. 2026. https://pubmed.ncbi.nlm.nih.gov/41110634/

Knudsen GM. Sustained effects of single doses of classical psychedelics in humans. Neuropsychopharmacology. 2023. https://pubmed.ncbi.nlm.nih.gov/35729252/ National Center for Complementary and Integrative Health. Psilocybin for Mental Health and Addiction: What You Need To Know. https://www.nccih.nih.gov/health/psilocybin-for-mental-health-and-addiction-what-you-need-to-know